| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 18.3 | 12.0 | 11.3 |
| Other income | 0.1 | 0.3 | 0.2 |
| Total income | 18.5 | 12.3 | 11.5 |
| Profit before exceptional items & tax | 2.0 | 1.9 | 1.2 |
| Exceptional items | 0.0 | 0.0 | 0.3 |
| Profit before tax | 2.0 | 1.9 | 1.6 |
| Net profit | 1.5 | 1.4 | 1.2 |
| Operating margin | 10.8% | 15.4% | 13.9% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +25.00% |
|---|---|
| Net profit, quarter on quarter | +7.10% |
| Revenue, year on year | +61.90% |
BSE results filing, BSE: 540204. Figures extracted from the filing.
Eiko Lifesciences Ltd: key numbers
- Share price
- ₹47.64
- Market cap
- ₹65.37 Cr
- Revenue (annual)
- ₹52.57 Cr
- Net profit (annual)
- ₹4.50 Cr
- P/E (TTM)
- 13.4×Sector 36.8×
- Promoter holding
- 39.91%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Eiko Lifesciences Ltd
All →Eiko Lifesciences Annual General Meeting
Eiko LifeSciences held its 49th Annual General Meeting on September 22, 2026. The meeting transacted business, including adoption of financial statements and appointment of directors.
Eiko Lifesciences Other Announcement
Eiko Lifesciences informed exchanges that it sent the AGM notice and Annual Report weblink to shareholders who have not registered email addresses.
Eiko Lifesciences Annual General Meeting
Eiko Lifesciences Limited has issued a notice for its 49th Annual General Meeting scheduled for September 22, 2026, to discuss financial statements and related matters.
- Value
- ₹252.3 Cr
Eiko Lifesciences Annual Report
Eiko Lifesciences Limited has announced its 49th Annual General Meeting, scheduled for September 22, 2026. The company has also filed its Annual Report for FY 2025-26.
Eiko Lifesciences Annual General Meeting
Eiko Lifesciences Limited will hold its 49th Annual General Meeting on September 22, 2026, via video conferencing to transact ordinary and special business.
Eiko Lifesciences Management Change
Eiko Lifesciences Limited has appointed Mr. Suraj Mahadev Gaikwad as an Additional Independent and Non-Executive Director, subject to approval by shareholders at the upcoming Annual General Meeting.